• CHROMED arises from the results of a previous FP7 project experience (Chronious “An Open, Ubiquitous and Adaptive Chronic Disease Management Platform for COPD and Renal Insufficiency”) and the experience gained in the field of monitoring physiological parameters at home gained by RESTECH in a previous observational study focused at studying daily fluctuation of lung function in patients affected by COPD (Chronic Obstructive Pulmonary Disease).

 

  • Worldwide, COPD (Chronic obstructive pulmonary disease) affects 329 million people, nearly 5% of the population. In 2011, COPD was ranked as the fourth-leading cause of death, killing over 3 million people, and responsible for over $2.1 trillion of dollars of expenses of the NHSs, resulting in a significant socio-economic burden. The number of patients affected by COPD is expected to increase according to the ageing of the population in developed countries. Telemedicine-based care models that enable early diagnosis and treatment of acute events (exacerbations) are advocated to reduce the socioeconomic impact of chronic diseases.